Focal adhesion alterations in <scp>G0</scp> ‐positive melanoma cells-Reference-Cited by-同舟云学术

Focal adhesion alterations in G0 ‐positive melanoma cells

Published:2022-12-19 Issue:6 Volume:12 Page:7294-7308
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Esimbekova Alexandra R.¹,Palkina Nadezhda V.¹,Zinchenko Ivan S.¹,Belenyuk Vasiliy D.²,Savchenko Andrey A.²,Sergeeva Ekaterina Yu¹,Ruksha Tatiana G.¹^ORCID

Affiliation:

1. Department of Pathophysiology Krasnoyarsk State Medical University Krasnoyarsk Russia

2. Laboratory of Cell Molecular Physiology and Pathology Federal Research Center, Krasnoyarsk Science Center of The Siberian Branch of The Russian Academy of Sciences Krasnoyarsk Russia

Funder

Russian Science Foundation

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5510

Reference59 articles.

1. Mechanisms of Resistance to BRAF-Targeted Melanoma Therapies

2. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis

3. Immune checkpoint inhibitors in melanoma

4. Phenotype plasticity as enabler of melanoma progression and therapy resistance

5. A slow-cycling/quiescent cells subpopulation is involved in glioma invasiveness

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of NRF2 transcription factor mediated by MIR-155 diminishes melanoma cell viability independently of redox status;Цитология;2024-06-05

2. Inhibition of the Expression of NRF2 Transcription Factor Mediated by miR-155 Causes a Decrease in the Viability of Melanoma Cells Regardless of Redox Status;Cell and Tissue Biology;2024-06

3. Tryptophan metabolism-related gene expression patterns: unveiling prognostic insights and immune landscapes in uveal melanoma;Aging;2023-10-13

4. Activation of the MAPK signal cascade components phosphorylation involved in the formation of the G0-positive tumor phenotype;Molekulyarnaya Meditsina (Molecular medicine);2023-02-14